Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06571812 · ClinicalTrials.gov registry record

A Clinical Study of the TSX Dental Implant System (Xpresso)

A clinical trial of Tooth Loss, sponsored by ZimVie.

Recruiting
Registry status
62
Enrollment target
2
Study locations

NCT06571812 is a study of Tooth Loss that is actively recruiting participants, run by ZimVie. The registered enrollment target is 62 participants, below the 98-participant average among 11 other Tooth Loss trials with a reported enrollment target (37% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06571812, a study of Tooth Loss, is actively recruiting participants, sponsored by ZimVie.

RECRUITING
Registry status
62 participants
Enrollment target
2
Study locations

Study Summary

A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations yearly for 2 years.

Conditions Studied

Tooth Loss

Interventions

  • DEVICE TSX

Study Locations (2)

Ohio

  • Ohio State University - Columbus

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2024-04-24
Est. Completion 2027-06

Sponsor

ZimVie

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06571812

The ClinicalTrials.gov registry entry for NCT06571812 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 11 other Tooth Loss trials with a reported enrollment target (37% lower). The listed sponsor is ZimVie, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tooth Loss appearing as the primary indexed condition, and to 1 intervention - of which TSX is the first listed.

NCT06571812 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06571812 about?

NCT06571812 is a clinical study titled "A Clinical Study of the TSX Dental Implant System (Xpresso)". A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations year...

What is the current status of trial NCT06571812?

This trial is currently recruiting. The enrollment target is 62 participants. The study started on 2024-04-24. Estimated completion is 2027-06.

What conditions does trial NCT06571812 study?

This clinical trial studies the following conditions: Tooth Loss.

What interventions are being tested in trial NCT06571812?

The interventions under investigation include: TSX (DEVICE).

Who is sponsoring clinical trial NCT06571812?

This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06571812 being conducted?

This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tooth Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tooth Loss

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.